DermTechの資産のリターン
DermTechの資産のリターン は何ですか。
DermTech, Inc.の資産のリターン は-68.96%です。
資産のリターン の定義は何ですか。
資産のリターンは 、企業の資産が収益を生み出す際の収益性を示します。純利益を平均総資産で除して計算されます。
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
NASDAQのセクタHealth Careにおける資産のリターン の企業と比べるDermTech
DermTechは何をしますか。
DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases, and aging-related conditions in the United States. It offers Pigmented Lesion Assay (PLA), a gene expression test that helps rule out melanoma and the need for a surgical biopsy of atypical pigmented lesions. The company also provides Nevome test, an adjunctive reflex test for the PLA; and adhesive skin sample collection kits, as well as gene expression assays for the Th1, Th2, IFN-gamma, and Th17 inflammatory pathways. In addition, it is developing UV damage DNA risk assessment products, as well as non-melanoma skin cancer diagnostic and cutaneous T-cell lymphoma rule out test products, as well as offering health-related and information services through electronic information and telecommunication technologies. The company sells its products primarily to pathology and oncology practitioners. DermTech, Inc. is headquartered in La Jolla, California.
DermTechと類似の資産のリターン
- Hanstone Goldの資産のリターン は-69.34%です。
- Next Dynamicsの資産のリターン は-69.30%です。
- Mint Paymentsの資産のリターン は-69.21%です。
- Antisense Therapeuticsの資産のリターン は-69.08%です。
- Provention Bioの資産のリターン は-69.08%です。
- Skeena Resourcesの資産のリターン は-69.04%です。
- DermTechの資産のリターン は-68.96%です。
- INmune Bioの資産のリターン は-68.94%です。
- Leaf of Faith Beverageの資産のリターン は-68.88%です。
- Vision Marine Technologiesの資産のリターン は-68.86%です。
- Axovant Gene Therapiesの資産のリターン は-68.72%です。
- Galectoの資産のリターン は-68.70%です。
- Eastern Metalsの資産のリターン は-68.52%です。